skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Intratumoral Injection of Hypertonic Glucose in Treating Refractory Pneumothorax Caused by Microwave Ablation: a Preliminary Study

Journal Article · · Cardiovascular and Interventional Radiology
 [1];  [2];  [3]
  1. Chinese Academy of Medical Sciences, Peking Union Medical College (China)
  2. National Center of Gerontology, Center of Minimally Invasive Therapies for Tumors, Beijing Hospital (China)
  3. Qingdao Municipal Hospital, Radiology Department (China)

Purpose: The purpose of this technical report is to describe the technique of intratumoral injection of hypertonic glucose combined with low-negative pressure drainage to treat refractory pneumothorax (RP) after microwave ablation (MWA) of lung tumors. Materials and Methods: Between September 2016 and May 2018, four patients who developed RP after MWA of peripheral lung cancer were managed by a combined method, including intratumoral injection of hypertonic glucose and catheter drainage under low-negative pressure. Blood gas values were recorded and compared before the treatment and one-week posttreatment. All patients were followed up for at least one month to monitor the possible recurrence of pneumothorax by chest CT. Results: All patients were successfully treated. One patient received the intratumoral injection of hypertonic glucose twice, while the remaining three patients received a single injection. The technical success rate was 100%. Dyspnea related to RP was significantly relieved in all patients, and PaO{sub 2} and SaO{sub 2} values were higher than those measured before treatment. No patient suffered a recurrence of pneumothorax during the follow-up. Conclusion: The combined method of intratumoral injection of hypertonic glucose and continuous catheter drainage under low-negative pressure might be an effective method to manage RP caused by MWA.

OSTI ID:
22969233
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 42, Issue 6; Other Information: Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
Country of Publication:
United States
Language:
English